Items related to Human Insulin: Clinical Pharmacological Studies in...

Human Insulin: Clinical Pharmacological Studies in Normal Man - Softcover

 
9789401083478: Human Insulin: Clinical Pharmacological Studies in Normal Man
View all copies of this ISBN edition:
 
 
Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin. Human insulin in quantities sufficiently large for therapy has been made available by two techniques developed in parallel during the late 1970s. These involve either (i) formulation in E. coli bacteria suitably encoded by DNA recombinant methods of the A- and B-chains of human insulin followed by a chain combination reaction ('biosynthetic' human insulin) or (ii) enzymatic conversion (transpeptidation) of porcine insulin brought to react with a threonine ester by porcine trypsin in a mixture of water and organic solvents, yielding human insulin ('semi-synthetic' human insulin). This book includes the first clinical-pharmacological studies of each of the highly purified 'semi-synthetic' human insulin preparations: Actrapid ® HM; Monotard® HM; Protaphane® HM; Actraphane® HM; and Ultratard® HM (Novo Industri A/S, Copenhagen). The preliminary studies established their safety and efficacy relative to their porcine and bovine counterparts emphasising the relevance of species and formulation on the pharmacokinetics and biological responses to insulin. Additional investigations with human insulin demonstrated the influence of insulin concentration, site of administration, the addition of aprotinin to insulin and the mixing of 'short-' and 'intermediate-acting' formulations on insulin 'bioavailability'. Examination of the 'within' and 'between' subject day-to-day variation in absorption and the effect of subcutaneous insulin also demonstrates the dominating influence of insulin responsiveness.

"synopsis" may belong to another edition of this title.

  • PublisherSpringer
  • Publication date2011
  • ISBN 10 9401083479
  • ISBN 13 9789401083478
  • BindingPaperback
  • Number of pages312

Other Popular Editions of the Same Title

9780852009512: Human Insulin: Clinical Pharmacological Studies in Normal Man

Featured Edition

ISBN 10:  0852009518 ISBN 13:  9780852009512
Publisher: Springer, 1986
Hardcover

Top Search Results from the AbeBooks Marketplace

Seller Image

Owens, D.R.
Published by Springer (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Soft Cover Quantity: 10
Seller:
booksXpress
(Bayonne, NJ, U.S.A.)

Book Description Soft Cover. Condition: new. Seller Inventory # 9789401083478

More information about this seller | Contact seller

Buy New
US$ 55.79
Convert currency

Add to Basket

Shipping: FREE
Within U.S.A.
Destination, rates & speeds
Stock Image

Owens, D.R.
Published by Springer (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Softcover Quantity: 18
Seller:
Lucky's Textbooks
(Dallas, TX, U.S.A.)

Book Description Condition: New. Seller Inventory # ABLIING23Apr0412070057864

More information about this seller | Contact seller

Buy New
US$ 59.29
Convert currency

Add to Basket

Shipping: US$ 3.99
Within U.S.A.
Destination, rates & speeds
Stock Image

D. R. Owens
Published by Springer (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Softcover Quantity: > 20
Print on Demand
Seller:
Ria Christie Collections
(Uxbridge, United Kingdom)

Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9789401083478_lsuk

More information about this seller | Contact seller

Buy New
US$ 63.36
Convert currency

Add to Basket

Shipping: US$ 12.50
From United Kingdom to U.S.A.
Destination, rates & speeds
Seller Image

D. R. Owens
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Taschenbuch Quantity: 2
Print on Demand
Seller:
BuchWeltWeit Ludwig Meier e.K.
(Bergisch Gladbach, Germany)

Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin. Human insulin in quantities sufficiently large for therapy has been made available by two techniques developed in parallel during the late 1970s. These involve either (i) formulation in E. coli bacteria suitably encoded by DNA recombinant methods of the A- and B-chains of human insulin followed by a chain combination reaction ('biosynthetic' human insulin) or (ii) enzymatic conversion (transpeptidation) of porcine insulin brought to react with a threonine ester by porcine trypsin in a mixture of water and organic solvents, yielding human insulin ('semi-synthetic' human insulin). This book includes the first clinical-pharmacological studies of each of the highly purified 'semi-synthetic' human insulin preparations: Actrapid ® HM; Monotard® HM; Protaphane® HM; Actraphane® HM; and Ultratard® HM (Novo Industri A/S, Copenhagen). The preliminary studies established their safety and efficacy relative to their porcine and bovine counterparts emphasising the relevance of species and formulation on the pharmacokinetics and biological responses to insulin. Additional investigations with human insulin demonstrated the influence of insulin concentration, site of administration, the addition of aprotinin to insulin and the mixing of 'short-' and 'intermediate-acting' formulations on insulin 'bioavailability'. Examination of the 'within' and 'between' subject day-to-day variation in absorption and the effect of subcutaneous insulin also demonstrates the dominating influence of insulin responsiveness. 308 pp. Englisch. Seller Inventory # 9789401083478

More information about this seller | Contact seller

Buy New
US$ 59.38
Convert currency

Add to Basket

Shipping: US$ 24.79
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

D.R. Owens
Published by Springer (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Paperback Quantity: 2
Seller:
Revaluation Books
(Exeter, United Kingdom)

Book Description Paperback. Condition: Brand New. 308 pages. 9.25x6.10x0.70 inches. In Stock. Seller Inventory # x-9401083479

More information about this seller | Contact seller

Buy New
US$ 76.08
Convert currency

Add to Basket

Shipping: US$ 12.52
From United Kingdom to U.S.A.
Destination, rates & speeds
Seller Image

D. R. Owens
Published by Springer Netherlands (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Taschenbuch Quantity: 1
Seller:
AHA-BUCH GmbH
(Einbeck, Germany)

Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin. Human insulin in quantities sufficiently large for therapy has been made available by two techniques developed in parallel during the late 1970s. These involve either (i) formulation in E. coli bacteria suitably encoded by DNA recombinant methods of the A- and B-chains of human insulin followed by a chain combination reaction ('biosynthetic' human insulin) or (ii) enzymatic conversion (transpeptidation) of porcine insulin brought to react with a threonine ester by porcine trypsin in a mixture of water and organic solvents, yielding human insulin ('semi-synthetic' human insulin). This book includes the first clinical-pharmacological studies of each of the highly purified 'semi-synthetic' human insulin preparations: Actrapid ® HM; Monotard® HM; Protaphane® HM; Actraphane® HM; and Ultratard® HM (Novo Industri A/S, Copenhagen). The preliminary studies established their safety and efficacy relative to their porcine and bovine counterparts emphasising the relevance of species and formulation on the pharmacokinetics and biological responses to insulin. Additional investigations with human insulin demonstrated the influence of insulin concentration, site of administration, the addition of aprotinin to insulin and the mixing of 'short-' and 'intermediate-acting' formulations on insulin 'bioavailability'. Examination of the 'within' and 'between' subject day-to-day variation in absorption and the effect of subcutaneous insulin also demonstrates the dominating influence of insulin responsiveness. Seller Inventory # 9789401083478

More information about this seller | Contact seller

Buy New
US$ 64.50
Convert currency

Add to Basket

Shipping: US$ 35.56
From Germany to U.S.A.
Destination, rates & speeds
Seller Image

D.R. Owens
Published by Springer Netherlands (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New Softcover Quantity: > 20
Print on Demand
Seller:
moluna
(Greven, Germany)

Book Description Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Since insulin became available for the treatment of diabetes in 1922 a number of major advances have been made, which include the modification of insulin to vary its timing of action, its purification, and latterly, the production of human insulin. Human in. Seller Inventory # 5834884

More information about this seller | Contact seller

Buy New
US$ 53.70
Convert currency

Add to Basket

Shipping: US$ 52.81
From Germany to U.S.A.
Destination, rates & speeds
Stock Image

Owens, D. R.
Published by Springer 2011-10 (2011)
ISBN 10: 9401083479 ISBN 13: 9789401083478
New PF Quantity: 10
Seller:
Chiron Media
(Wallingford, United Kingdom)

Book Description PF. Condition: New. Seller Inventory # 6666-IUK-9789401083478

More information about this seller | Contact seller

Buy New
US$ 92.44
Convert currency

Add to Basket

Shipping: US$ 18.77
From United Kingdom to U.S.A.
Destination, rates & speeds